Does type 1 diabetes change the microRNA expression profile on the uterus of ovariectomized mice submitted or not to estrogen replacement?

• Grant number: 14/23517-1
• Support Opportunities: Scholarships abroad - Research Internship - Post-doctor
• Start date: December 01, 2014
• End date: November 30, 2015
• Field of knowledge: Biological Sciences - Morphology - Cytology and Cell Biology
• Principal Investigator: Telma Maria Tenório Zorn
• Grantee: Rodolfo Favaro Ribeiro
• Supervisor: Udo R. Markert
• Host Institution: Instituto de Ciências Biomédicas (ICB). Universidade de São Paulo (USP). São Paulo , SP, Brazil
• Institution abroad: Friedrich Schiller University Jena, Germany
• Associated to the scholarship: 11/22429-3 - EVALUATION OF THE IMPACT OF TYPE 1 DIABETES UPON THE RESPONSIVINESS OF UTERINE TISSUES TO ESTROGEN STIMULATION, BP.PD

Abstract

Our group has established a mouse model of type 1 diabetes to investigate the impact of this disease on reproduction, particularly on the uterine environment (Favaro et al., 2010, 2013, 2104; FAPESP Grants: 07/55277-6 and Doctoral Fellowship: 04/14442-6). Through this model we showed that diabetes impairs endometrial decidualization and remodeling of the decidual extracellular matrix (ECM) (Favaro et al., 2013) as well as the structure, cell proliferation and ECM of the pregnant myometrium (Favaro et al., 2010; 2014). Bearing in mind that both uterine cell proliferation and ECM remodeling are regulated by estrogen and progesterone (Ramathal et al., 2009; Salgado et al., 2009, 2011, 2013; FAPESP Grants: 10/52543-0), we hypothesized that impairments on these processes by diabetes may be due to alterations on hormonal signaling in uterus. To investigate this question, we submitted alloxan-induced type 1 diabetic females to ovariectomy followed or not by estrogen treatment. (FAPESP Postdoctoral Fellowship: 11/22429-3). Estrogen and progesterone have been shown to regulate miRNA expression in the reproductive and non-reproductive organs. In the uterus of OVX mice, estrogen treatment modulates the proteins responsible for miRNA processing and maturation (Nothnick et al., 2010) as well as specific subsets of miRNAs (Nothnick and Healy, 2010). Estrogen treatment increased mirn155, mirn429 and mirn451 and reduced mirn181b and mirn204, miRNAs that may contribute to regulate genes associated to cell proliferation and ECM remodeling (Nothnick and Healy, 2010). The proliferative actions of estrogen are mediated by its action upon the expression of transcription factors, growth factors, cell cycle machinery components and miRNAs. MiRNAs are intimately related to cell proliferation control by targeting several mRNAs of cell cycle-associated molecules. For instance, miR-206 (Elliman et al., 2014), miR-365 (Kim et al., 2014), and many others have the capability to target cyclin D1 mRNA. Similarly, p27 transcript is regulated by the interaction with miR-221 and miR-222 (le Sage et al. 2007).Considering the major biological roles played by miRNAs in cellular behavior, we hypothesized these molecules may play a role in the alterations promoted by diabetes in the uterine environment. In this context, the goal of this research proposal is to investigate whether type 1 diabetes impacts on the miRNA expression profile in the uterus of ovarectomized mice submitted or not to estrogen treatment. Bioinformatical analysis of this data will indicate the targets of the miRNAs potentially altered by diabetes. The screening of miRNAs will provide informative data that may contribute to clarify the association between diabetes reproductive disorders. (AU)

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

PHOTINI, STELLA MARY; CHAIWANGYEN, WITTAYA; WEBER, MAJA; AL-KAWLANI, BOODOR; FAVARO, RODOLFO R.; JESCHKE, UDO; SCHLEUSSNER, EKKEHARD; MORALES-PRIETO, DIANA M.; MARKERT, UDO R.. PIM kinases 1, 2 and 3 in intracellular LIF signaling, proliferation and apoptosis in trophoblastic cells. Experimental Cell Research, v. 359, n. 1, p. 275-283, OCT 1 2017. (14/23517-1, 11/22429-3)

FAVARO, RODOLFO R.; MORALES-PRIETO, DIANA M.; HERRMANN, JOERG; SONNEMANN, JUERGEN; SCHLEUSSNER, EKKEHARD; MARKERT, UDO R.; ZORN, TELMA M. T.. Influence of high glucose in the expression of miRNAs and IGF1R signaling pathway in human myometrial explants. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, v. 303, n. 6, FEB 2021. (14/23517-1, 13/16922-4)